| 3/22/2024 | 293590900029 | ROSUVASTATIN FOR IMPURITY L IDENTIFICATION CRS, ROSUVASTATIN IMPURITY G CRS, ROSUVASTATIN IMPURITY MIXTURE CRS, ROSUVASTATIN FOR SYSTEM SUITABILITY CRS, ROSUVASTATIN FOR PEAK IDENTIFICATION CRS (HUMAN DRUG RAW MATERIAL SAMPLE) | 5 | UNIT | 445 | N/A | NOBEL İLAÇ SANAYİİ VE TİCARET ANONİM ŞİRKETİ |
| 3/4/2024 | 293359950038 | ETHYLENE HYDROXY IMPURITY 1 BOTTLE 10 MG /DIR**HUMAN DRUG REFERENCE STANDARD ARTICLE | 10 | MILLIGRAM | 236 | N/A | BİEM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
| 3/12/2024 | 293379000019 | ARIPIPRAZOLE IMPURITY F (HUMAN DRUG RAW/MATERIAL SAMPLE) | 9 | MILLIGRAM | 99 | N/A | NOBEL İLAÇ SANAYİİ VE TİCARET ANONİM ŞİRKETİ |
| 3/26/2024 | 292800902019 | DRUG ACTIVE INGREDIENT IMPURITS FOR USE IN PHARMACEUTICAL RESEARCH (CARBIDOPA IMPURITY BGHJ-E+-F (60 MG X 6 VIAL) | 0 | GRAM | 891 | N/A | ELİXİR İLAÇ ARAŞTIRMA VE GELİŞTİRME ANONİM ŞİRKETİ |
| 3/20/2024 | 293410000019 | MELOXİCAM IMPURITY STANDARD((HUMAN DRUG/RAW MATERIAL SAMPLE) | 1 | UNIT | 174 | N/A | NOBEL İLAÇ SANAYİİ VE TİCARET ANONİM ŞİRKETİ |
| 3/27/2024 | 292800902019 | DRUG ACTIVE INGREDIENT IMPURITIES FOR USE IN PHARMACEUTICAL RESEARCH (CARBIDOPA IMPURITY AD)+ | 0 | GRAM | 671 | N/A | ELİXİR İLAÇ ARAŞTIRMA VE GELİŞTİRME ANONİM ŞİRKETİ |
| 3/19/2024 | 292529000019 | CHLORHEXIDINE DIACETATE EP IMPURITY H 10 MG, CHLORHEXIDINE DIACETATE EP IMPURITY K 10 MG*HUMAN DRUG+ RAW MATERIAL SAMPLE* | 20 | MILLIGRAM | 1720 | N/A | NOBEL İLAÇ SANAYİİ VE TİCARET ANONİM ŞİRKETİ |
| 3/15/2024 | 291639909019 | FLURBIPROFEN EP IMPURITY B (HUMAN DRUG / RAW MATERIAL SAMPLE) 20 MG | 1 | UNIT | 370 | N/A | NOBEL İLAÇ SANAYİİ VE TİCARET ANONİM ŞİRKETİ |
| 3/29/2024 | 293499909027 | QUETIAPINE EP IMPURITY N (HUMAN DRUG HA/MMMATTER SAMPLE) | 10 | MILLIGRAM | 240 | N/A | NOBEL İLAÇ SANAYİİ VE TİCARET ANONİM ŞİRKETİ |
| 3/7/2024 | 291639909019 | BEXAROTONE IMPURITY 10 MG, BEXAROTONE WS/ 100 MG *HUMAN DRUG RAW MATERIAL SAMPLE* | 110 | MILLIGRAM | 380 | N/A | NOBEL İLAÇ SANAYİİ VE TİCARET ANONİM ŞİRKETİ |